Login
Register
Your login | |
Your password | |
Confirm your password | |
Your email | |
I agree to receive the R3i newsletter | |
Titles | |
1988 | MD, Chiba University Medical School, Japan |
1996 | PhD, Uppsala University, Sweden |
1998 | DMSci, Chiba University Graduate School of Medicine |
Professional Associations | |
2005- | Member of the Guideline Committee, Japan Atherosclerosis Society |
2009- | Member of the Guideline Committee, Japan Association of Obesity Research |
2010- | Director, Japan Atherosclerosis Society |
2010- | Councilor, Japan Endocrinology Association |
2010- | Councilor, Japan Diabetes Association |
2010- | Member, American Diabetes Association |
2011- | Executive Editor, Geriatrics and Gerontology International |
2012- | Director, Japanese Society for Clinical Molecular Medicine |
2012- | Director, Japan Clinical Nutrition Society |
2013- | Councilor, The Japanese Society of Internal Medicine |
2013- | Director, Japan Association of Obesity Research |
2014- | Director, Japan Geriatric Society |
2015- | Councilor, The Japanese Association of Medical Sciences |
2015- | Joint Committee Member of the Japan Geriatric Society and Japan Diabetes Society for Guidelines for the management of diabetes in the elderly |
2019- | Director, The Japanese Society of Internal Medicine |
Honors | |
2002 | Research Award, Japan Heart Foundation |
2005 | 2005 Young Investigators Award, Japan Society of Diabetes Complication |
2012 | Goto Yu-ichiro Award, Japan Atherosclerosis Society |
Certification | |
1998 | Medical Doctor, Japan, License# 312586 |
1989 | Educational Commission for Foreign Medical Graduates, USA, Certificate# 419-336-3 |
1991 | Japanese Board of Internal Medicine, Japan, Certification# 2009115 |
2000 | Japanese Board of Geriatrics, Japan, Certification# 309009 |
2001 | Japanese Board of Diabetes, Japan, Certification# 2009115 |
2016 | Japanese Board of Endocrinology, Japan, Certification# 1160099 |
Clinical speciality | |
Diabetes, lipid disorders and Werner syndrome. | |
Research interest | |
Prevention and treatment of atherosclerosis, diabetic complications and progerioid syndrome. | |